Announcements Categories Investors Our Board Our Principal Advisors Announcements Reports Corporate Governance Share Registry Investor Enquiries Our Technology Presentations About Us July 26, 2022 Genetic Signatures (ASX:GSS) – Clinical Trial Recruitment Completed for US Enteric Kit View Announcement May 13, 2022 Genetic Signatures (ASX:GSS) – Appointment of Non-Executive Director, Caroline Waldron View Announcement March 31, 2022 Quarterly Activities Report and Appendix 4C View Announcement March 30, 2022 Genetic Signatures (ASX.GSS) – Public Health Wales View Announcement February 18, 2022 18 February 2022- GSS Half Yearly Report View Announcement February 17, 2022 Genetic Signatures (ASX.GSS) – Investor Webinar Presentation View Announcement January 10, 2022 Genetic Signatures (ASX:GSS) – Saliva-Based Protocol for SARS-CoV-2 View Announcement December 21, 2021 Genetic Signatures (ASX:GSS) – Investor Update ASX: GSS – Investor Update November 23, 2021 Genetics Signatures (ASX:GSS) – Application for quotation of securities ASX: GSS –Application for quotation of securities November 23, 2021 Genetics Signatures (ASX:GSS)- Notification of cessation of securities ASX: GSS – Notification of cessation of securities « Previous 1 … 8 9 10 11 12 … 26 Next » View GSS ASX Announcements on asx.com.au
